Imagine a future where cancer treatment affects only the tumor, where eye injections are no longer required and brain surgeries don’t result in large incisions or long recovery times. That’s the future researchers at Michigan State University are working toward.

Cancer fighters know that losing their hair is often part of the battle, but Michigan State University researchers have developed a shampoo-like gel that has been studied in animal models and could protect hair from falling out during chemotherapy treatment.

Four dedicated researchers from Michigan State University have received grants totaling more than $3 million from the American Cancer Society, or ACS, to find new ways to prevent, detect, treat and help patients survive colorectal, breast and cervical cancer.

Henry Ford Health + Michigan State University Health Sciences has named the award recipients of the 2024 Cancer Seed Funding Program. Building on the success of the 2022 and 2023 cancer research pilot and integration award funding initiatives, this year the program awarded 14 new cancer research awards totaling $700,000.

Inflammation of the arteries is a primary precursor and driver of cardiovascular disease — the No. 1 killer of people in the United States. This inflammation is associated with the buildup of dangerous plaque inside the arteries.

The American Cancer Society (ACS), the largest non-government, non-profit funding source of cancer research in the U.S., recently approved funding for a Michigan State University researcher’s project to fight cancer.

Researchers at Michigan State University have teamed up to create a new way to image immune cells in living subjects that could enable new treatment opportunities and better outcomes for patients with Type 1 diabetes.

Bryan R. Smith is an associate professor of biomedical engineering and a member of the Institute for Quantitative Health Science & Engineering. His lab blends engineering, chemistry, biology, physics, and medicine to develop new imaging and therapeutic approaches.

Cardiovascular disease is the world’s leading cause of death, killing nearly 20 million people every year. In the United States, it was responsible for one in every five deaths in 2020, according to the Centers for Disease Control.

Apple and MSU have partnered to launch the tech giant's first U.S.-based Developer Academy in Detroit. Dean Leo Kempel said the college and MSU will help Apple in its efforts to enlarge the diverse community of Detroit-based innovators.

Michigan State and Stanford researchers have upgraded their Trojan horse therapies designed to fight one of the world's leading causes of death.

Compostable dog poop bags aren't panning out. "Biodegradability is the most used and abused term," said Ramani Narayan. The word carries little regulatory oversight and leaves customers thinking their purchase has a smaller impact on the environment than it does. Story featured in Discover Magazine.

With a nearly $2.6 million grant from the National Institutes of Health, Michigan State University researchers are using nanoscopic particles to turn the body's own cells into weapons that cancer won't see coming.

University Distinguished Professor Anil Jain is ranked #1 in the world in the 2020 edition of Top Scientists Ranking for Computer Science & Electronics, according to Guide2Research, one of the leading portals for computer science research.

A first-of-its-kind nanoparticle-based in vivo imaging technique that may one day be used to help diagnose and even treat cancer has been developed by researchers collaborating from Michigan State, Johns Hopkins and Stanford universities.

Research led by MSU is showing ways that hackers can use ultrasonic waves to secretly control voice assistant devices. Called "SurfingAttack" the attack leverages the unique properties of acoustic transmission in solid materials — such as tables — to "enable multiple rounds of interactions between the voice-controlled device and the attacker."

Bryan Smith, associate professor of biomedical engineering, and a team of scientists have created a "Trojan Horse" nanoparticle that can be directed to eat debris, reducing and stabilizing plaque. The discovery could be a potential treatment for atherosclerosis, a leading cause of death in the United States.

Like a video game ghost chomping along a maze to advance to the next level, a novel nanotech therapy created by scientists at Michigan State University and Stanford University have discovered a way to eat away portions of the plaques that cause heart attacks.

Dirk Colbry's "side hustle" as a PhD student at MSU helped him develop into one of the country's "Sherpas of Supercomputing." Colbry is the director of high performance computing studies in the Department of Computational Mathematics, Science and Engineering.

Bryan Smith, associate professor in the Department of Biomedical Engineering, has created a noninvasive process to deliver chemotherapy treatments that could help doctors see how much of the drug is going directly to the tumor.

Michigan State University scientists have invented a new way to monitor chemotherapy concentrations, which is more effective in keeping patients' treatments within the crucial therapeutic window.

The future of self-driving vehicles may be drizzling out - at least in Michigan, CANVAS Director and ECE professor Hayder Radha tells the industry-leading publication, Automotive News. "When we run these algorithms, we see very noticeable, tangible degradation in detection," Radha said.

The race is on to create cheap materials to store energy for the U.S power grid, said Mechanical Engineering Department Chair James Klausner. MSU is sharing a $2 million award from the U.S. Department of Energy's Advanced Research Projects Agency-Energy (ARPA-E). "We think we can return electricity to the grid at less than 5 cents per kilowatt hour," he said.

Researchers from Michigan State University and Stanford University have created a computer simulation, validated by experimental results, to help design drug-delivery nanoparticles that carry cancer-fighting medicines directly to tumors, while minimizing the potential side-effects on healthy cells.